Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
792 7 |
Ultima descărcare din IBN: 2023-03-22 23:57 |
Căutarea după subiecte similare conform CZU |
616.36-006.04-089.843 (1) |
Patologia sistemului digestiv. Tulburări ale tubului alimentar (1732) |
SM ISO690:2012 TARAN, Natalia, IVANCOV, Grigore, LUPAŞCO, Iulianna, HOTINEANU, Adrian. Carcinomul hepatocelular sub aspectul includerii recipientului în lista de așteptare. In: Sănătate Publică, Economie şi Management în Medicină , 2017, nr. 4(74), pp. 131-134. ISSN 1729-8687. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Sănătate Publică, Economie şi Management în Medicină | ||||||
Numărul 4(74) / 2017 / ISSN 1729-8687 /ISSNe 2587-3873 | ||||||
|
||||||
CZU: 616.36-006.04-089.843 | ||||||
Pag. 131-134 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
The incidence of hepatocellular carcinoma (HCC) is over 600 000 new cases/year, growing steadily in both Europe and United States. HCC is situated on the sixth place places among the most common cancers localizations worldwide and is the third leading cause of cancer death. Chronic patients with hepatitis B virus (HBV) present a 100 times higher risk of developing HCC than non-infected people in the general population. Approximately 170 million people worldwide are infected with hepatitis C virus, of which 20-30% progress to cirrhosis and these patients present a risk of HCC of 3-5% per year. Liver transplantation in HCC patients is seen by the EASL Expert Committee through four concepts: 1) policy of prioritization and exclusion from the waiting list; 2) neoadjuvant therapy for patients awaiting transplantation; 3) extending the criteria and reducing the transplant stage; 4) liver transplantation from a living donor |
||||||
Cuvinte-cheie hepatocellular carcinoma, liver transplant, MELD score, Milano criteria, San Francisco criteria |
||||||
|